Targeting nitric oxide to its targets (43950F)

Experimental Biology and Medicine

Volumn 211, Issue 1, 1996, Pages 41-48

  Bredt, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SPECTRIN;

CONFERENCE PAPER; NEUROTRANSMISSION; REGULATORY MECHANISM; SECOND MESSENGER; SYNTHESIS; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; DYSTROPHIN; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0030061167     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholinel Nature 288(5789):373-376, 1980.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327(6122):524-526, 1987.
3. Ferrendelli JA, Chang MM, Kinscherf DA. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. J Neurochem 22:535-540, 1974.
4. Biggio G, Brodie BB, Costa E, Guidotti A. Mechanisms by which diazempam, muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc Natl Acad Sci USA 74(8):3592-3596, 1977.
5. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336(6197):385-388, 1988.
6. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86(22):9030-9033, 1989.
7. Garthwaite J, Garthwaite G, Palmer RM, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172(4-5):413-416, 1989.
8. Burnstock G, Campbell G, Bennett M, Holman ME. Biochem Pharmacol 12:134, 1963.
9. Burnstock G. Neurotransmitters and trophic factors in the autonomic nervous system. (review lecture) J Physiol (Lond) 313:1-35, 1981.
10. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 52(3):352-357, 1983.
11. Bowman A, Gillespie JS, Pollock D. Oxyhaemoglobin blocks non-adrenergic non-cholinergic inhibition in the bovine retractor penis muscle. Eur J Pharmacol 85(2):221-224, 1982.
12. Martin W, Villani GM, Jothanandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232(3):708-716, 1985.
13. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neurol role for nitric oxide. Nature 347(6295):768-770, 1990.
14. Costa M, Furness JB, Pompolo S, Brookes SJ, Bornstein JC, Bredt DS, Snyder SH. Projections and chemical coding of neurons with immunoreactivity for nitric oxide synthase in the guinea-pig small intestine. Neurosci Lett 148(1-2):121-125, 1992.
15. Llewellyn-Smith IJ, Song ZM, Costa M, Bredt DS, Snyder SH. Ultrastructural localization of nitric oxide synthase immunoreactivity in guinea-pig enteric neurons. Brain Res 577(2):337-342, 1992.
16. Berezin I, Snyder SH, Bredt DS, Daniel EE. Ultrastructural localization of nitric oxide synthase in canine small intestine and colon. Am J Physiol 266(4 Pt 1):C981-C989, 1994.
17. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88(7):2811-2814, 1991.
18. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7(4):615-624, 1991.
19. Gally JA, Montague PR, Reeke GN Jr., Edelman GM. The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA 87(9):3547-3551, 1990.
20. Bohme GA, Bon C, Stutzmann JM, Doble A, Blanchard JC. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol 199(3):379-381, 1991.
21. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88(24):11285-11289, 1991.
22. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254(5037):1503-1506, 1991.
23. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 8(2):211-216, 1992.
24. Schuman EM, Madison DV. Locally distributed synaptic potentiation in the hippocampus. (see comments) Science 263(5146):532-536, 1994.
25. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349(6307):326-328, 1991.
26. Kartell NA. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. Neuroreport 5(7):833-836, 1994.
27. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MC. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265(5171):542-546, 1994.
28. Lum-Ragan JT, Gribkoff VK. The sensitivity of hippocampal long-term potentiation to nitric oxide synthase inhibitors is dependent upon the pattern of conditioning stimulation. Neuroscience 57(4):973-983, 1993.
29. Haley JE, Malen PL, Chapman PF. Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices. Neurosci Lett 160(1):85-88, 1993.
30. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 372:546-548, 1994.
31. Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316(2):175-180, 1993.
32. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin in and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752, 1995.
33. Cho KO, Hunt CA, Kennedy MB. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9(5):929-942, 1992.
34. Bryant PJ, Woods DF. A major palmitoylated membrane protein of human erythrocytes shows homology to yeast guanylate kinase and to the product of a Drosophila tumor suppressor gene. (letter) Cell 68(4):621-622, 1992.
35. Willott E, Balda MS, Flanning AS, Jameson B, Van Itallie C, Anderson JM. The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc Natl Acad Sci USA 90(16):7834-7838, 1993.
36. Jesaitis LA, Goodenough DA. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J Cell Biol 124(6):949-961, 1994.
37. Adams ME, Butler MH, Dwyer TM, Peters MF, Murnane AA, Froehner SC. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11(3):531-540, 1993.
38. Ahn AH, Yoshida M, Anderson MS, Feener CA, Selig S, Hagiwara Y, Ozawa E, Kunkel LM. Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24. Proc Natl Acad Sci USA 91(10):4446-4450, 1994.
39. Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. J Biol Chem 266(14):9161-9165, 1991.
40. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244(4912):1578-15780, 1989.
41. Koenig M, Monaco AP, Kunkel LM. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53(2):219-226, 1988.
42. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355(6362):696-702, 1992.
43. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345(6273):315-319, 1990.
44. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269(19):13729-13732, 1994.
45. Campanelli JT, Roberds SL, Campbell KP, Scheller RH. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77(5):663-674, 1994.
46. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77(5):675-686, 1994.
47. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 269(19):13725-13728, 1994.
48. Drapier JC, Hibbs JB Jr. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 78(3):790-797, 1986.
49. Garthwaite J Giutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14(2):60-67, 1991.
50. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330(9):613-622, 1994.
51. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265(5180):1883-1885, 1994.
52. Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, West MS. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 73(5):1797-1804, 1992.
53. Reid MB, Shoji T, Moody MR, Entman ML. Reactive oxygen in skeletal muscle. II. Extracellular release of free radicals. J Appl Physiol 73(5):1805-1809, 1992.
54. Davison A, Tibbits G, Shi ZG, Moon J. Active oxygen in neuromuscular disorders. Mol Cell Biochem 84(2):199-216, 1988.
55. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112(1):135-148, 1991.
56. Webster C, Silberstein L, Hays AP, Blau HM. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52(4):503-513, 1988.
57. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87(2): 682-685, 1990.
58. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351(6329):714-718, 1991.
59. Hecker M, Mulsch A, Busse R. Subcellular localization and characterization of neuronal nitric oxide synthase. J Neurochem 62(4):1524-1529, 1994.
60. Aoki C, Fenstemaker S, Lubin M, Go CG. Nitric oxide synthase in the visual cortex of monocular monkeys as revealed by light and electron microscopic immunocytochemistry. Brain Res 620(1):97-113, 1993.